Masaki Morishita

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 9

Top Topics

Renal Cell Carcinoma

Computed Tomography

Top Venues

Molecular pharmaceutics

This page only lists publications with an associated author ORCID identifier.

Publications

Masaki Morishita, Masakatsu Kida, Tomomi Motomura, Rihito Tsukamoto, Mizuho Atari, Kazuya Higashiwaki, Kisa Masuda, Hidemasa Katsumi, Akira Yamamoto
Elucidation of the Tissue Distribution and Host Immunostimulatory Activity of Exogenously Administered Probiotic-Derived Extracellular Vesicles for Immunoadjuvant. Molecular pharmaceutics (2023)
Kohei Ogawa, Hidemasa Katsumi, Yasushi Moroto, Masaki Morishita, Akira Yamamoto
Processing Parameters and Ion Excipients Affect the Physicochemical Characteristics of the Stereocomplex-Formed Polylactide-b-Polyethylene Glycol Nanoparticles and Their Pharmacokinetics. Pharmaceutics 14 (3) (2022)
Hidemasa Katsumi, Sho Kitada, Shintaro Yasuoka, Rie Takashima, Tomoki Imanishi, Rina Tanaka, Satoru Matsuura, Hiroyuki Kimura, Hidekazu Kawashima, Masaki Morishita, Akira Yamamoto
L-Serine-Modified Poly-L-Lysine as a Biodegradable Kidney-Targeted Drug Carrier for the Efficient Radionuclide Therapy of Renal Cell Carcinoma. Pharmaceutics 14 (9) (2022)
Masaki Morishita, Maho Horita, Ayaka Higuchi, Maho Marui, Hidemasa Katsumi, Akira Yamamoto
Characterizing Different Probiotic-Derived Extracellular Vesicles as a Novel Adjuvant for Immunotherapy. Molecular pharmaceutics 18 (3) (2021)
Hiroki Ukai, Kazuki Iwasa, Takamasa Deguchi, Masaki Morishita, Hidemasa Katsumi, Akira Yamamoto
Enhanced Intestinal Absorption of Insulin by Capryol 90, a Novel Absorption Enhancer in Rats: Implications in Oral Insulin Delivery. Pharmaceutics 12 (5) (2020)
Tammam Alama, Kosuke Kusamori, Masaki Morishita, Hidemasa Katsumi, Toshiyasu Sakane, Akira Yamamoto
Mechanistic Studies on the Absorption-Enhancing Effects of Gemini Surfactant on the Intestinal Absorption of Poorly Absorbed Hydrophilic Drugs in Rats. Pharmaceutics 11 (4) (2019)
Chonlada Charoenviriyakul, Yuki Takahashi, Masaki Morishita, Makiya Nishikawa, Yoshinobu Takakura
Role of Extracellular Vesicle Surface Proteins in the Pharmacokinetics of Extracellular Vesicles. Molecular pharmaceutics 15 (3) (2018)
Satoru Matsuura, Hidemasa Katsumi, Hiroe Suzuki, Natsuko Hirai, Rie Takashima, Masaki Morishita, Toshiyasu Sakane, Akira Yamamoto
l-Cysteine and l-Serine Modified Dendrimer with Multiple Reduced Thiols as a Kidney-Targeting Reactive Oxygen Species Scavenger to Prevent Renal Ischemia/Reperfusion Injury. Pharmaceutics 10 (4) (2018)
Masaki Morishita, Yuki Takahashi, Makiya Nishikawa, Reiichi Ariizumi, Yoshinobu Takakura
Enhanced Class I Tumor Antigen Presentation via Cytosolic Delivery of Exosomal Cargos by Tumor-Cell-Derived Exosomes Displaying a pH-Sensitive Fusogenic Peptide. Molecular pharmaceutics 14 (11) (2017)